Clinical Trial

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Trial Details
NCT Number NCT04161768
Lead Sponsor Tanta University
Conditions Spontaneous Bacterial Peritonitis
Enrollment 80 participants
Start Date 2018-12-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2019-11-13